FSP 43rd Annual Anatomic Pathology Conference



Make plans to attend the Florida Society of Pathologists 2017 Annual Anatomic Pathology Conference taking place February 17-19, at Disney's Grand Floridian Resort. The 2017 Conference will feature the most innovative topics in pathology and provide practicing pathologists educational opportunities on new scientific applications and technologic advances.

In addition to the educational offerings, there will be numerous opportunities for attendees to connect with colleagues and network during exhibit hall social functions. The exhibit hall will feature the most prominent industry leaders in the field of pathology showcasing their best products and services.  We encourage all attendees to make their reservations as soon as possible. Please visit the venue page for more information on discounted rates and to book your room at Disney's Grand Floridian Resort. Discounted tickets to the Disney parks are available to FSP attendees. To purchase discounted tickets please visit this link.

We look forward to another great conference and seeing you in February!

The Grand Floridian Resort is now sold out on Saturday, February 18th. We apologize for any Inconvenience this may cause. Click here for more hotel options.

Online registration for 43rd Annual Anatomic Pathology Conference is now closed. We will be accepting registrations onsite. If you have any questions please call the Florida Society of Pathologist's office at 904-309-6261.

By registering for the Florida Society of Pathologists 43rd Annual Anatomic Pathology Conference, attendee understands and agrees that attendee’s name, city, and state may be shared with other attendees and exhibitors. By allowing an exhibitor to scan the conference badge, attendee understands, agrees and consents to the sharing of attendee’s contact information with the company that scanned the conference badge.

By registering for this Conference, I also give FSP the right to publish all photos, videos, etc. taken at this Conference.

Cancellation Policy: A written notice of cancellation must be received by January 17, 2017 in order to receive a refund. Cancellations received prior to this date will be honored minus a $100 administration fee. There will be no refunds if cancelling within 30 days of the meeting start date. Refunds will not be honored after January 17, 2017. Telephone cancellations cannot be accepted. Cancellation refunds will be processed within 30 days after the conclusion of the Conference.


Ralph H. Hruban, MD

Baxley Professor and Director of Pathology

Johns Hopkins University, School of Medicine

Baltimore, MD


Dr. Ralph Hruban is the Baxley Professor and Director of Pathology at the Johns Hopkins University School of Medicine and Pathologist-in-Chief for The Johns Hopkins Hospital.  He received his undergraduate degree from the University of Chicago and is a 1985 Johns Hopkins School of Medicine alumnus.  He completed his residency training at Hopkins and he spent one year as a Fellow at Memorial Sloan-Kettering Cancer Center in New York.  After completing his fellowship, Dr. Hruban returned to Johns Hopkins in 1990 to join the faculty. 


Dr. Hruban is also the Director of The Sol Goldman Pancreatic Cancer Research Center. The pancreatic cancer research team at Johns Hopkins contains many of the world’s leading experts in pancreatic cancer.  Through their extensive research, they have discovered many of the fundamental genetic changes that drive pancreatic cancer.  Dr. Hruban also serves as a member of the Scientific Advisory Board of The Joseph C. Monastra Foundation, The Michael Rolfe Pancreatic Cancer Foundation, and The Lustgarten Foundation.


He has received numerous awards including the Arthur Purdy Stout Prize for significant career achievements in surgical pathology, the Ramzi Cotran Award from the United States and Canadian Academy of Pathology, the PanCAN Medical Visionary Award, the Team Science Award from the American Association for Cancer Research, the Ruth Brufsky Award for Excellence in Clinical Research for Pancreatic Cancer, the Frank H. Netter Award for Special Contributions to Medical Education, the Ranice W. Crosby Distinguished Achievement Award for scholarly contributions to the advancement of art as applied to the sciences, the Ruth Leff Siegel Award for Excellence in Pancreatic Cancer Research, and the 2013 Johns Hopkins University Distinguished Alumni Award. Dr. Hruban has also received five teaching awards from the Johns Hopkins University School of Medicine.


Dr. Hruban has written over 700 scientific papers, 100 book chapters and reviews, and 6 books.  His research contributions include the characterization of “PanINs,” the precursor lesions that give rise to invasive pancreatic cancer.  He received recognition from the Institute for Scientific Information as a highly cited researcher and from Essential Science Indicators as the most highly cited pancreatic cancer scientist.  In addition to his research efforts, Dr. Hruban founded The National Familial Pancreas Tumor Registry at Johns Hopkins and helped to create the Johns Hopkins Pancreatic Cancer Web Page.  He also created an award-winning iPad application to teach pancreas pathology, and recently produced an award-winning documentary on the life of William Stewart Halsted (http://HalstedTheDocumentary.org).   


Gregory Y. Lauwers, MD
Senior Member
H. Lee Moffitt Cancer Center & Research Institute
Professor of Pathology
Morsani College of Medicine, University of South Florida
Tampa, FL

Dr. Gregory Y. Lauwers is a Senior Member at the H. Lee Moffitt Cancer Center and Research Institute and Professor of Pathology at the Morsani College of Medicine at the University of South Florida. His research has focused on oncologic surgical pathology of the gastrointestinal tract. Dr. Lauwers has published over 300 peer-reviewed articles, editorials, reviews, and book chapters, and is coauthor of several textbooks, including the 5th edition of Morson and Dawson's Gastrointestinal Pathology and Advances in Surgical Pathology: Gastric Cancer. Dr. Lauwers serves on the editorial boards of several journals, and he is Deputy Editor-in-Chief of the Archives of Pathology and Laboratory Medicine. He served on the Editorial and Consensus Working Group for the WHO Classification of Tumours Series, 4th Ed., and contributed to the WHO Classification of Tumours of the Digestive System (2010). Dr. Lauwers is also Clinical Professor, University of Western Australia; and Adjunct Professor, Pusan National University School of Medicine. 


L. Jeffrey Medeiros, MD
Professor and Chair
Department of Hematopathology
The University of Texas, MD Anderson Cancer Center
Houston, TX

Dr. Medeiros received his MD from the University of Massachusetts and did residency in Anatomic and Clinical Pathology at the New England Deaconess Hospital in Boston (now Beth Israel/Deaconess Medical Center). He also completed four years of fellowship training: two years at Stanford University Medical Center (Surgical Pathology and !mmunopathology), one year at Massachusetts General Hospital (Hematopathology), and one year at the National Cancer Institute (Hematopathology). His first job as a junior staff position was at the National Cancer Institute. His first senior staff position was an Associate Professor of Pathology at Rhode Island Hospital/Brown University of School of Medicine in Providence, Rhode Island. He subsequently was appointed Director of Hematopathology at City of Hope National Medical Center in Duarte, California. In 1998, he joined the faculty at MD Anderson and became the first Chair of the newly created Department of Hematopathology in 2002.

Dr. Medeiros is a member of the editorial boards of a number of journals including the major diagnostic pathology journals American Journal of Clinical Pathology, American Journal of Surgical Pathology, Archives of Pathology and Laboratory Medicine, Human Pathology, and Modern Pathology. He is co­author of three books: Loachim's Lymph Node Pathology (Lippincott Williams & Wilkins, 2007) , Diagnostic Pathology: Lymph Nodes and Spleen with Extranodal Lymphomas (AMIRSYS, 2011), and Atlas of Lymph Node Pathology (Springer, 2013). Dr. Medeiros has over 700 peer review publications. His interests include the diagnostic aspects of lymphoid neoplasms, including the use of histologic, immunophenotypic and particularly molecular methods for diagnosis and prognosis.


Emily E. Volk, MD, MBA, FCAP
Governor, CAP Board of Governors
Council on Government and Professional Affairs
Chief Quality Officer, Baptist Health System
San Antonio & Dallas, TX
Dr. Volk also serves as a National Physician Advisor for Blood Utilization - Tenet Healthcare, located in Dallas. Dr. Volk serves as the vice chair of the CAP's Council on Government and Professional Affairs. She is also a member of the CAP's Political Action Committee (PathPAC). Dr. Volk received her MD from University of Missouri. She completed her residency at the Cleveland Clinic Foundation in Cleveland, Ohio, and her fellowship at William Beaumont Hospital in Royal Oak, Michigan. She is board certified in anatomic and clinical pathology and cytopathology. 

Bruce M. Wenig, MD

Senior Member, Anatomic Pathology
Section Head, Head & Neck, and Endocrine Pathology
Moffitt Cancer Center
Professor of Oncologic Sciences, University of South Florida


Bruce M. Wenig, MD, is the Section Head, Head and Neck, and Endocrine Pathology at the Moffitt Cancer Center in Tampa, FL, and Professor at the University of South Florida Oncological Sciences. Prior to moving to the Moffitt Cancer Center, Dr. Wenig was Site Chairman in the Department of Pathology at Mount Sinai Beth Israel, Mount Sinai St. Luke’s and Mount Sinai West, as well as the Vice Chairman for Anatomic Pathology in the Mount Sinai Health System New York, NY.  Dr. Wenig is board certified in Anatomic and Clinical Pathology having completed his residency training in the Department of Pathology at the Mount Sinai Medical Center New York, NY (1981-1985). Following his residency training, Dr. Wenig completed a Fellowship in Surgical Pathology at the Cedars Sinai Medical Center in Los Angeles, CA (1985-1986) and a Fellowship in Otolaryngic Pathology at the Armed Forces Institute of Pathology in Washington, DC (1986-1987). Following his Fellowship training, Dr. Wenig was a Staff Pathologist in the Department of Otorhinolaryngic and Endocrine Pathology at the Armed Forces Institute of Pathology (1987-1998), and served as the Division Chief for Otorhinolaryngic Pathology. From 1998-2001, Dr. Wenig was the Vice Chairman for Anatomic Pathology in the Department of Pathology at the Albert Einstein College of Medicine Bronx, NY. From 2001-2003, Dr. Wenig was the Vice Chairman for Anatomic Pathology in the Department of Pathology and Laboratory Medicine at Continuum Health Partners, including Beth Israel Medical Center, St. Luke’s Hospital and Roosevelt Hospital (2001-2003). In 2003, Dr. Wenig was named Chair of the Department of Pathology at Continuum Health Partners and held this position through October 2016.

Dr. Wenig’s main clinical interests are in diseases of the head and neck, and endocrine organs. Dr. Wenig has published extensively (116 manuscripts) in peer reviewed journals as well as authoring/editing several textbooks and numerous book chapters on Head and Neck, and Endocrine Pathology. Recently, the third edition of his single authored book entitled “Atlas of Head and Neck Pathology” was published (2016). 




Friday, February 17, 2017

1:00 pm – 1: 15 pm
1:15 pm – 2:15 pm
Gastric Polyps & Dysplasias: A Review of an Ever Expanding List
Gregory Y. Lauwers, MD
2:15 pm – 3:15 pm
Gastritides: Diagnostic Evaluation of Multifaceted Conditions
Gregory Y. Lauwers, MD
3:15 pm – 3:45 pm
Refreshment Break with Exhibitors
3:45 pm – 4:45 pm
What is New and Worth Discussing in Chronic Colitis & Associated Dysplastic Lesions
Gregory Y. Lauwers, MD
4:45 pm – 6:00 pm
Welcome Reception with Exhibitors

Saturday, February 18, 2017

7:30 am – 8:15 am
Continental Breakfast with Exhibitors and Digital Poster Sessions
8:15 am – 8:20 am
Morning Notes and Overview
8:20 am - 9:05 am
MACRA: Update on Quality Payment Program
Emily E. Volk, MD, MBA, FCAP
9:05 am – 10:05 am
An Algorithmic Approach to Neoplasms of the Pancreas – Ductal Adenocarcinoma vs. Chronic Pancreatitis
Ralph H. Hruban, MD
10:05 am – 11:05 am
An Algorithmic Approach to Neoplasms of the Pancreas – Solid Neoplasms
Ralph H. Hruban, MD
11:05 am – 11:35 am
Refreshment Break with Exhibitors and Digital Poster Sessions
11:35 am – 12:35 pm
An Algorithmic Approach to Neoplasms of the Pancreas – Cystic Neoplasms
Ralph H. Hruban, MD
12:35 pm – 12:50 pm
12:50 pm - 2:25 pm
FSP Business Luncheon and Legislative Session
2:30 pm – 3:45 pm
Interactive Microscopy Course and Case Presentations - Slides in hematopathology and both pancreatic and gastrointestinal cytology will be presented.
Ofiong Ikpatt, MD; Evita Henderson-Jackson, MD; Kun Jiang, MD, PhD
3:45 pm – 4:45 pm
Read Slides with FSP Expert Faculty, Interactive Microscopy - Salivary Gland Pathology
Bruce M. Wenig, MD
5:00 pm - 6:30 pm
Fellowship Fair and Resident Forum

Sunday, February 19, 2017

7:45 am – 8:30 am
Continental Breakfast with Exhibitors
8:30 am – 8:35 am
Morning Notes and Overview
8:35 am – 9:35 am
Diffuse Large B-cell Lymphoma
L. Jeffrey Medeiros, MD
9:35 am – 10:35 am
Marginal Zone Lymphomas
L. Jeffrey Medeiros, MD
10:35 am – 11:05 am
Refreshment Break with Exhibitors
11:05 am – 12:05 pm
Mimics of Lymphoma
L. Jeffrey Medeiros, MD
12:05 pm – 12:15 pm
Closing Remarks



Disney's Grand Floridian Resort 

4401 Floridian Way

Lake Buena Vista, FL 32830


FSP Annual Meeting attendees will receive a discounted room rate starting at $302/night plus taxes/per night. To make a reservation online please click here or call 407-939-4686 and ask for the FSP Rate. The cut off date is January 18, 2017.

Discounted Disney park tickets are available to FSP attendees. To purchase a discounted ticket please visit this link

The Grand Floridian Resort is now sold out on Saturday, February 18th. We apologize for any Inconvenience this may cause. See below for some other hotel options:


Hilton Bonnet Creek

14100 Bonnet Creek Resort Lane

Orlando, FL 32821

Reservations: (888) 353.2013

Distance from Grand Floridian: 7 miles (14 min. Drive)

Rate: From $219/a night plus tax

Daily resort Charge of $30 a night plus tax to include, wifi, kid’s meal deals, 2 bottles of water daily, 10% off spa treatments, access to fitness center, free golf club rental after 2 pm.

Self-parking: $20 plus tax; Valet: $26 plus tax



Hyatt Regency Grand Cypress

One Grand Cypress Blvd.

Orlando, Florida, 32836, USA

Reservations: (407) 239 1234

Distance for Grand Floridian: 10 miles (20 min drive)

Rate: Starting at $239/a night Plus tax

Daily resort fee of $25 plus tax will be added and includes scheduled transportation to Disney, Universal and Sea World, watersports, and rentals.

Self-parking: $17 a day, Valet: $25/night



Disney’s Port of Orleans Riverside Resort

1251 Riverside Drive

Lake Buena Vista, Florida 32830-8514

Reservations: (407) 934-6000

Distance from the Grand Floridian: 6.5 miles (12 min drive)

Rate: Starting at $269/night plus tax

Self-parking is complimentary to Resort Guests.



Free self-parking is available at the Grand Floridian Resort by the Convention Center.


FSP 43rd Annual Anatomic Pathology Conference

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Florida Medical Association and the Florida Society of Pathologists. The Florida Medical Association is accredited by the ACCME to provide continuing medical education for physicians.

The Florida Medical Association designates this live activity for a maximum of 12.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Statements of credit will be awarded based on the participant’s attendance at each session and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form.  If you have questions about this CME/CE activity, please contact the FSP at 904-309-6219. Credit must be claimed by February 28, 2017.


This activity is designed to meet the needs of practicing physicians, pathologists, and other specialists involved with anatomic pathology.

The field of anatomic pathology is constantly changing, and many of the most important advances in the field. In the setting of new technology, techniques and advancements in the field, practice gaps are inevitable. As such, pathologists require ongoing educational opportunities to stay current in order to maintain and improve their knowledge and competence in the field.


  • At the conclusion of this activity, all participants should be able to:
  • Examine grading systems and new criteria for pathologic diagnoses in the areas covered.
  • Appraise the proper application of immunohistochemical and other molecular techniques for the diagnosis of problematic cases.
  • Evaluate the most recent histopathological classifications of various gastrointestinal neoplasms.
  • Differentiate between chronic pancreatitis and ductal adenocarcinoma.
  • Describe the key distinguishing features of the most common solid neoplasms of the pancreas.
  • Explain how nuclear features can aid in the diagnosis of solid neoplasms of the pancreas.
  • Examine the key distinguishing features of the most common cystic neoplasms of the pancreas.
  • Assess clinical, morphologic and immunophenotypic findings in diffuse large B-cell lymphoma recognized in the World Health Organization classification.
  • Distinguish the three subtypes of marginal zone lymphoma recognized in the World Health Organization classification.
  • Analyze entities that can mimic various types of lymphoma.

This activity is supported by an educational grant from Celgene and in-kind support from Leica Biosystems and OptraSCAN.

The planners of this activity disclosed no ­financial relationships relevant to the content to be presented.


Name Relationship Company
John H. Armstrong, MD, FACS N/A Nothing to Disclose
Richard C. Friedberg, MD, PhD, FCAP N/A Nothing to Disclose
Evita Henderson-Jackson, MD N/A Nothing to Disclose
Ralph H. Hruban, MD Royalty Payments Myriad Genetics
Kun Jiang, MD, PhD N/A Nothing to Disclose
Gregory Y. Lauwers, MD N/A Nothing to Disclose
L. Jeffrey Medeiros, MD N/A Nothing to Disclose
Ikpatt Offiong, MD N/A Nothing to Disclose
Emily E. Volk, MD, MBA N/A Nothing to Disclose
Bruce Wenig, MD N/A Nothing to Disclose
Qihui Jim Zhai, MD




Springer and LWW



We invite you to participate as a sponsor and exhibitor in the Florida Society of Pathologists 2017 Annual Anatomic Pathology Conference taking place on February 17-19 in Orlando, FL. Interact and showcase your products and services with approximately 200-250 pathologists from the state of Florida.


Exhibit Hall Hours

Friday, February 17, 2017

Exhibitors Set Up: 8:00 AM – 2:00 PM

Exhibit Hall Open: 3:15 PM – 6:00 PM


Saturday, February 18, 2017 

Exhibit Hall Open: 7:30 AM – 11:35 AM


Sunday, February 19, 2017     

Exhibit Hall Open: 7:45 AM – 11:05 AM


For more information on exhibiting or sponsoring please contact Vivian Grifantini at 904-309-6212 or by email at vgrifantini@flpath.org

Download the Exhibitor Prospectus

Download Exhibitor Service Kit

Download Lead Retrieval Form



Learn more about cutting-edge products and services during the newly added innovation labs while you enjoy breakfast or hors d’oeuvres.  Innovation labs are non-CME and occur in the morning or evening after the FSP sessions are over.


Next Generation Sequencing and the Genoptix Approach

Friday, February 17, 6:00 - 6:45 PM 

Speaker: Derek Lyle, M.D., Director of Hematopathology, Genoptix, Inc., Cartesian Medical Group

Learn how the latest molecular testing (targeting genomic alterations)—combined with Genoptix user-friendly lab reports and verbal pathologists’ consultations—help physicians hold more informed discussions with their patients.

Sponsored by Genoptix Medical Laboratory


Afirma GEC Testing of Cytologically Indeterminate Thyroid Nodules to Safely Avoid Unnecessary Surgery

Breakfast provided

Saturday, February 18, 6:45 - 7:30 AM 

Speaker: Richard T. Kloos, MD, Senior Medical Director, Endocrinology, Veracyte, Inc

Afirma GEC’s high sensitivity and high negative predictive values assist pathologists and treating physicians to accurately identify cytologically indeterminate thyroid nodules with benign molecular signatures so that unnecessary surgeries can be avoided. The Afirma GEC is the only molecular diagnostic test for this purpose supported by published multicenter prospective blinded clinical validation, analytical validation, cost-effectiveness, and multiple clinical utility studies. Veracyte accepts all insurance providers and eliminates all financial risk to the hospital and providers.

Sponsored by Veracyte, Inc.


Healthcare Payments are Changing - Are You Prepared?

Food and beverages provided 

Saturday, February 18, 5:00 - 5:45 PM 

Speaker: William Todd Andros, CEO, tevixMD

The number of patients with high-deductible health plans has increased. Insurance companies are not paying until the patient’s deductibles have been met. Healthcare providers have to transition to a retail healthcare model where they get paid! Attend tevixMD’s innovation lab to discover how to get your company paid!

Sponsored by tevixMD

Click Here to Register


To host an Innovation Lab, please contact Vivian Grifantini at 904-309-6212 or by email at vgrifantini@flpath.org.



APS Medical Billing

APS Medical Billing is a premier billing company that provides expert billing and practice management solutions to practices nationwide.  Some of the services provided include expert ICD-10 and CPT coding, contract management, and comprehensive charge capture systems to ensure its client’s financial success.



ARUP Laboratories

A nonprofit, academic enterprise of the University of Utah, ARUP Laboratories offers more than 3,000 tests and test combinations. ARUP’s Anatomic Pathology Division consists of more than 50 expert pathologists who provide a full range of consultative and diagnostic services, ranging from flow cytometry and molecular diagnostics to surgical pathology. For more information, visit: http://www.aruplab.com/ap


Cell Marque, a Part of MilliporeSigma

Cell Marque's expansive portfolio of IVD antibodies, detection chemistries and reagents for immunohistochemistry are tested and validated to ensure consistent quality for you and your patients.



College of American Pathologists

As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, read the CAP Annual Report at cap.org.


CSI Laboratories 

CSI Laboratories is a specialized cancer diagnostics laboratory focused on meeting the unique needs and challenges of pathologists. Independently owned and operated by medical professionals, CSI has offered expert diagnostic testing to pathologists across the U.S. since 1997. Testing offered by CSI includes flow cytometry, cytogenetics, FISH, IHC, and molecular diagnostics.



Dako, Agilent Pathology Solutions

Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. The company generated revenues of $4.0 billion in fiscal 2014 and employs about 12,000 people worldwide. Agilent marks its 50th anniversary in analytical instrumentation this year. In 2012, Agilent acquired Dako, a well-known provider of reagents, instruments, software and expertise to make accurate diagnoses and determine the most effective treatment for cancer patients. Information about Agilent is available at www.agilent.com and information about Dako products is available here.


Discern Management Group, LLC.

The goal of Discern Management Group is to help you maximize revenue and minimize concerns. Discern provides an overall understanding of the business side of your practice.  Since Discern is not affiliated with a billing service, our independence allows an unbiased review of your entire practice. Discern will partner with the physician group to maximize income for services already being performed and help stop the trend of decreasing annual revenue. Partnering with Discern gives you the peace of mind that your practice is reaching its maximum potential, allowing you to focus your efforts on patient care and medicine.




Faxitron is the world’s largest and only fully vertically integrated, dedicated cabinet x-ray company.  With an installed base of over 7,000 systems in medical facilities and scientific research laboratories around the globe, Faxitron is the industry standard in cabinet x-ray systems for specimen radiography, research, and NDT applications.  For more than 40 years, Faxitron has defined cabinet x-ray by developing x-ray sensor technology and innovative systems to meet the evolving needs of our customers.  



Foundation Medicine 

Foundation Medicine is leading a transformation in cancer care, where each patient's treatment is informed by a deep understanding of the molecular changes that contribute to their disease. We provide three best-in-class genomic tests for patients-FoundationOneR for solid tumors, FoundationOneR Heme for hematologic malignancies and sarcomas, and FoundationACTT for patients where tissue biopsy is not feasible.



Gator Medical Books

Gator medical books provides the medical community with the latest titles from Elsevier, Mc Graw Hill and other publishers.  We offer books journals and electronic media at a discounted price.




Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. We are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline.



Genoptix Medical Laboratory 

Genoptix, a Novartis company, is a leading CAP-accredited and CLIA-certified specialized laboratory focused on delivering diagnostic services to hematology/oncology patients and the physicians who treat them. Our team includes over 200 trained professionals with PhDs, clinical laboratory scientists and pathologists−including over 30 board-certified hematopathologists, molecular pathologists and geneticists. Genoptix is an established center of excellence for oncology testing, specializing in five disease areas: breast, hematology, lung, melanoma and colorectal cancer. Experience matters when interpreting oncology results.



Interpace Diagnostics

ThyGenX and ThyraMIR combination testing helps to better assess the risk of thyroid nodules being either benign or malignant – and helps reduce unnecessary surgeries.  ThyGenX / ThyraMIR can be performed in corresponding stained cytology or FFPE cell block slides as well as archival specimens.



Kellison & Company

Since 1976, the principals of Kellison & Company have specialized in providing comprehensive revenue cycle management services to Pathology practices including outreach, hospital-based AP practices, molecular labs and clinical professional component practices. Kellison’s goal is to help improve cash flow, reduce administrative costs and enhance patient satisfaction. The company provides credentialing services, turning around denials and reporting options to help you monitor your current financial status as well as to predict future trends.



The KEW Group

The KEW Group offers clinicians the CancerPlex. CancerPlex is a next generation DNA sequencing test for solid tumors. The specific coding regions of over 400 known cancer genes are simultaneously determined using a small amount of DNA extracted from tumor samples, including formalin-fixed, paraffin-embedded (FFPE) tissue and cell blocks from fine-needle aspirates or effusions. This analysis is performed in a single assay, simplifying and streamlining the test ordering process, and eliminating time consuming serial testing. Clinically actionable information unique to each patient’s tumor is consolidated into a simple report.



Leica Biosystems

Leica Biosystems is a global leader in workflow solutions and automation. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is represented in over 100 countries. It has manufacturing facilities in 9 countries, sales and service organizations in 19 countries, and an international network of dealers. The company is headquartered in Nussloch, Germany. Visit LeicaBiosystems.com for more information.


MagMutual Insurance Company

MagMutual offers comprehensive risk management and patient safety programs and is committed to an unwavering defense of our policyholders’ personal and professional reputations. 




McKesson, processing over 54 million procedures annually, can help pathologists improve financial performance, successfully manage complex payer models, increase referrals and minimize regulatory risks.



MedReceivables Advisor, LLC

MedReceivables is a full service medical billing company for the hospital based physician specializing in the Pathology arena in Florida. Our Expertise is in helping implement an economic and efficient receivables solution with the convenience of outsourced medical billing.




With more than 40 years of providing billing, coding and compliance solutions to Florida pathologists, you can trust our expertise. Using advanced analytics and billing technology along with our highly trained staff, Medusind improves your collections, boosts your efficiency and keeps you compliant with the ever-changing industry regulations.




From developing new therapies that treat and prevent disease to helping people in need, we're committed to improving health and well-being around the world.



MLabs - University of Michigan

Driving tomorrow’s health care solutions with today’s cutting edge personalized laboratory diagnostics. With 25+ years of reference laboratory experience, MLabs brings together advanced molecular testing and informatics capabilities in their fully accredited laboratories housed in one of the world’s most advanced medical facilities.  Nationally recognized and accessible faculty provides comprehensive testing and consultation service to physicians, hospitals and laboratories.  



NeoGenomics Laboratories 

NeoGenomics is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-licensed facilities across the U.S., but work hard to maintain easy access and all the efficiencies of a smaller operation.



NovoPath, Inc.

NovoPath™ is a comprehensive easy to use Anatomic Pathology Information Management and Reporting system with features in the core application for managing and resulting Surgical, Cytology, Derm, Molecular and Autopsy specimens. In addition to its Web Outreach Module (reporting, order entry, resulting, interfacing), NovoPath™ offers dedicated modules for Flow Cytometry and Cytogenetic testing.  Additional features include automatic organ map annotation, remote color printing, advanced security and full HL7 connectivity to HL7 standardized EMRs, HIS and LIS applications. 




OptraSCANTM (RUO), On-Demand Digital Pathology provides an affordable, small footprint, turnkey Digital Pathology solution for low and high-throughput usage, fluorescence and frozen sections. OptraSCANTM is a perfect tool for the transition from conventional microscopy to Digital Pathology for acquiring whole slide images, viewing/management, sharing/telepathology and analysis of digital slides and metadata.




PhenoPath, PLLC is a physician-owned specialty pathology practice and reference laboratory providing diagnostic and contract research services to pathology and oncology practices, hospitals, biopharmaceutical companies and research institutions in the U.S., Canada and around the world.



Physicians Independent Management Services, Inc.

Physicians Independent Management Services (PIMS) is a pathology specialized medical billing/ practice revenue company founded by pathologists, for pathologists. Our operations, located solely within the US, are led by a highly experienced team of senior health care professionals certified in coding, billing, compliance, IT, and accounting. For information, visit www.pims-inc.com or contact us at 813-490-7206.


Professional Casualty Corporation

Professional Casualty Corporation is a full service, multi-solution insurance broker dedicated to helping physicians find affordable Malpractice Insurance with reliable insurance providers.  They have over 30 years of experience serving the professional liability insurance needs of the healthcare community. PCC has negotiated additional discounts specifically for FSP members for their Medical Malpractice Insurance, through NORCAL Mutual.



Proscia Inc.

Proscia is using modern computing technology to improving clinical outcomes and accelerating the discovery of breakthrough advancements in the fight against cancer.



Psyche Systems Corporation

Psyche Systems' laboratory information software are best-of-breed products designed to meet the specific needs of Anatomic Pathology, Toxicology, Microbiology, and Molecular laboratories. We at Psyche work closely with our customer base during product development to ensure we are delivering the highest quality products and services at a competitive price. For more information, visit www.psychesystems.com


Quest Diagnostics

Quest Diagnostics empowers people to take action to improve health outcomes.  Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.  Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. 



Quantum Medical

Quantum Medical is a privately owned physician practice management company specializing in medical billing and management services for hospital-based physicians. Beginning its practice management in 1987, with a solo physician practice who is still a valued client today, Quantum Medical has helped physician practices with one goal in mind—“To optimize reimbursement through efficient practice management and billing procedures.” Quantum Medical continues to develop and excel in all phases of practice management and medical billing that result in “Putting Good Management into Practice!”



Roche Diagnostics 

Roche Tissue Diagnostics is one of the world’s leaders in medical diagnostic instrument and reagent systems providing leading-edge automation for use in the diagnosis of cancer and infectious disease.



Rosetta Genomics

Rosetta Genomics works to improve the lives of patients by leveraging expertise in diagnostic and therapeutic innovations. Rosetta discovers, develops and commercializes next generation diagnostic tests for personalized medicine, which are available through its CAP accredited, CLIA certified labs in Philadelphia, PA and Lake Forest, CA. 



Seattle Genetics

Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer. We are the industry leader in antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells.



SEO Enterprises, Inc. 

Pathology microscope sales and on-site microscope service for the state of Florida since 1969. - Your authorized Nikon pathology microscope dealer for the sunshine state.



Stemline Therapeutics 

Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company developing novel therapeutics that target cancer stem cells (CSCs) and tumor bulk.




TELCOR is the leader of revenue cycle management software solutions empowering laboratories to improve back office processes by streamlining revenue cycle workflow, reducing labor-intensive processes and operating costs. TELCOR RCM provides visibility to business operations. Reducing labor costs, increasing efficiencies and improving metrics helps laboratories increase collections and improve profitability.




tevixMD is an innovative, cloud-based solutions company whose focus is to get  healthcare providers paid. tevixMD has developed tevixPAS an industry-changing front-end solution that validates patients and provides payments prior to or at the time of service.  With the changes in healthcare, high patient deductibles and the challenge of securing reimbursements from payers, healthcare providers need to ensure they get paid. Visit www.tevixMD.com to request a demo.


UF Health Pathology

UF Health Pathology Laboratories is the largest academic outreach pathology laboratory in Florida, providing comprehensive pathology services to hospitals and physician groups throughout the state. 



Vachette Pathology

What is your revenue strategy? How are you preparing for MIPS and value payments?  Who is watching your wallet? We work with 5% of the pathologist nationwide.  Perhaps it is time to talk.  Vachette Pathology can help. We specialize in pathology revenue cycle consultation and revenue strategy.



Veracyte, Inc.

Veracyte, Inc. develops the Afirma® Thyroid FNA Analysis, centering on the proprietary and clinically validated Afirma Gene Expression Classifier (GEC). Afirma genomic testing identifies benign thyroid nodules with indeterminate cytology to help reduce diagnostic surgeries and guide surgical choice.



Vitro Molecular Laboratories

Over the last ten years, Vitro Molecular Laboratories has been providing esoteric services to academic institutions, biotechnology companies, community hospitals and major healthcare systems, nationally and internationally. Services include: Immunohistochemistry (IHC), FISH, Cytogenetics, Flow Cytometry, PCR and technical only services in flow cytometry, FISH and IHC. Vitro has redefined the concept of anatomic pathology esoteric service offerings, considering service components such as comprehensive esoteric testing menu, fast turnaround time, and friendly customer support not the end objective of our services, but the beginning of a much more involved relationship with our clients.



Wolters Kluwer

Wolters Kluwer Health is a global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Major brands include Lippincott Williams & Wilkins (the publisher of JONA, Official Leadership Journal of the Magnet Recognition Program® and Lippincott’s Nursing Solutions) and Ovid, online information search, discovery and management solutions.


FSP 2017 Resident Digital Poster Competition

Submission Deadline Extended: Monday, January 16, 2017 at 5:00 p.m. EST

The 2017 Florida Society of Pathologists (FSP) Poster Review Committee invites the submission of posters for the Resident Digital Poster Competition at the Florida Society of Pathologists 2017 Annual Anatomic Pathology Conference, February 17-19, at the Disney's Grand Floridian Resort. Residents, fellows, trainees and students who are resident members of the FSP and enrolled in a full time approved training program in pathology or sub-specialty of pathology in the state of Florida are welcome to participate.

Submitted posters that follow the guidelines below will be entered for the digital poster competition. The FSP Poster Review Committee will pre-judge posters on content. During the conference, the poster presentations will also be judged. The top three presenters (combined scores) will receive awards.  

All posters must be submitted online via the ePosterBoards submission website, and authors must register for the FSP 2017 Annual Anatomic Pathology Conference. Please be sure to read all instructions, information, and policies closely before submitting your poster. The online poster submission does not allow you to save and return to resume at a later time. Before starting your submission, have all materials and information ready.

Poster Submission Deadline

Wednesday, January 11, 2017

New submission deadline: 

Monday, January 16, 2017
5:00 p.m. EST


The three top posters will be awarded prizes. The first place winner will receive $500, the second place winner will win $250, and the third place winner will receive $150.

To be considered for the competition, you have to submit your poster by the submission deadline.

Presentation Methods

All posters that follow the guidelines will be displayed in the digital poster hall on electronic displays on Saturday, February 18. Presenters will have to be present during their assigned time to present their poster to the judge.

To ensure that the poster will be visually appealing on the digital screen, please follow the guidelines below from ePosterBoards.


The purpose of the poster competition is to stimulate research, provide a venue to share innovative and effective educational programs, showcase unique research projects, and to encourage networking among residents.

Poster Submission Instructions

Please read through the submission instructions below before preparing your poster:

  1. Read the general information and policies for the submission of a poster.
  2. Register for the 2017 Annual Anatomic Pathology Conference, pay the registration and fee. 
  3. Review the acceptance and presentation process for posters.
  4. Go to eposterboards.com/e-poster-upload/ and create your poster by following the poster guidelines above.
  5. Submit your posters online by January 16, 2017 at 5:00 p.m. EST.

General Information and Policies

  • Lead authors have to be a resident member of FSP to submit a poster. Resident members are residents, fellows, trainees and students in the State of Florida who are in a full time approved training program in pathology or sub-specialty of pathology. If you are not a member yet, please click here to become a member today. Membership is complimentary while you are in training.
  • You must register for the 2017 Annual Anatomic Pathology Conference at the resident rate, and pay a $50 submission fee for submission of poster.
  • It is the responsibility of the submitter to ensure that his/her poster is submitted correctly.
  • Posters submitted not for the competition, are accepted, but authors still have to regsister for the meeting, pay the fine and attend the meeting to present their poster. Please email poster@flpath.org if you do not want to be entered in the competition before January 17 to notify FSP.
  • Posters submitted by the deadline will be judged by the Poster Review Committee. Posters will be judged twice. The first round will be done before the conference, and it will be a blind review. The second judging session will be live at the conference in the digital poster hall. If your poster is submitted after the deadline, your poster will be displayed in the digital poster hall but will NOT be entered into the competition.
  • Full disclosure of all authors must be provided by the time of submission. Any failure to fully comply with this requirement may result in the poster being withdrawn from the poster hall and competition.
  • Faxed, emailed or mailed hard-copy posters or posters sent on a CD/disc WILL NOT be accepted. If you are unable to submit via the website, please contact the FSP Communications Staff:

    Contact: Judith Thomas
    Phone: (904) 309-6225
    Fax: (904) 998-0855
    Email: poster@flpath.org


The FSP will not be responsible for submissions not received via the website or for submission errors caused by Internet service outages, hardware or software delays, power outages, or unforeseen events.

Poster Guidelines

Content Guidelines

Poster entries submitted for competition can only be accepted electronically and must adhere to the following guidelines:

  • Posters must have one central theme, include essential data and test, and be visually appealing.
  • Posters must be proofread carefully to avoid errors before submission.
  • Posters must contain generic drug names only.
  • Posters must be submitted in clear English with accurate grammar and spelling of quality suitable for publication.
  • Lead and secondary authors must disclose all financial relationships.
  • Any funding support for the research must be disclosed.
  • Encore research is not eligible for submission.
  • Posters must not contain hyperlinks, videos, GIF files, and must be one slide only.

E-PosterBoard Guidelines

Download the guidelines, instructions, FAQs, and template.


You will be asked for the following:

  1. Short poster title (40-character title for use on onsite signage)
  2. Author name(s)
  3. Financial disclosures
  4. Disclosure of funding support
  5. Topic
  6. Payment of registration and submission fee

Poster Topics

The poster must relate to an appropriate topic in the field of pathology. Poster authors will be required to indicate which topic BEST matches the content of their abstract. Topics for the 2017 Resident Digital Poster Competition are:

  • Blood Banking/Transfusion Medicine
  • Chemical Pathology
  • Clinical Informatics
  • Cytopathology
  • Dermatopathology
  • Forensic Pathology
  • Hematopathology
  • Medical Microbiology
  • Molecular Genetic Pathology
  • Neuropathology
  • Pediatric Pathology
  • Selective Pathology
  • Case Study
  • Other

If you do not see an appropriate topic listed above that best relates to your poster, please contact the FSP office at posters@flpath.org or call 904-309-6225.

Acceptance and Presentation Process

After submission, you will receive an automated email to confirm your submission. If you do not receive the email within 24 hours, please contact the FSP office. Poster grading is blinded and posters are pre-judged and selected by FSP judges on the basis of quality, innovation, approach/design, and visuals. All lead poster authors are required to register for the 2017 Annual Anatomic Pathology Conference* February 17-19, 2017 at the Disney's Grand Floridian Resort in Orlando to present their poster to judges.

Onsite judging times will be assigned by Thursday, February 9, and authors will be notified of their presentation time.

Winners will be announced and prizes will be awarded during the business luncheon on Saturday, February 18.

*Expenses related to registration, airfare, lodging, and social events/guest fees are the responsibility of the presenter.

Questions? Contact the FSP office at poster@flpath.org or call 904-309-6225.


Calling all Residents and Fellows! FSP to host a Fellowship Fair and Resident Forum

The Florida Society of Pathologists (FSP) will hold a fellowship fair and resident forum showcasing the various fellowship programs in Florida and the southeast area. The fair will take place on Saturday, February 18 from 5:00-6:30 pm. This is a unique opportunity to learn about the fellowship programs available to pathology residents and fellows.

Confirmed Fellowship Programs to date include:

  • Moffitt Cancer Center Fellowship Programs: Hematopathology, Surgical Pathology, Cytopathology, Breast  Pathology, GI Pathology, Dermatopathology, Molecular Pathology
  • Mount Sinai Medical Center
  • University of Miami
  • University of Florida, Department of Pathology, Immunology and Laboratory Medicine, Cytopathology Fellowship

More programs are being added each week so check back here for more details!

After meeting with the fellowship programs, FSP will host a resident forum with FSP board members and prominent pathology thought leaders representing the various fields of pathology practice including clinical, laboratory, hospital based and academic. Residents will be able to ask their most pressing questions and receive career advice from the various thought leaders in attendance. 

We hope you will join us!

Cocktails and light hors d ‘oeuvres will be served.

Residents and Fellows at FSP meeting

FSP meeting

Fellow and Residents